Cost of revenue decreased 21.3%
Cost of revenue changed -21.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cost of revenue changed -21.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -17368 basis points from the comparable as-filed period.
Receivables / revenue changed +20532 basis points from the comparable as-filed period.
R&D / revenue changed +27607 basis points from the comparable as-filed period.
Operating cash-flow margin changed -163533 basis points from the comparable as-filed period.
Current liabilities changed -5.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
SBC / revenue changed -53439 basis points from the comparable as-filed period.
Operating income changed +3.4% from the comparable as-filed period.
Gross profit changed +1539.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
R&D / revenue changed -128659 basis points from the comparable as-filed period.
Operating cash-flow margin changed +360320 basis points from the comparable as-filed period.
Current liabilities changed +3.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.